Medtronic likely to seek Covidien renegotiation
US medical device maker Medtronic is likely to try to renegotiate the structure and terms of its $42.9bn deal to buy Dublin-based Covidien in response to new US tax rules, according to people familiar with the situation.
Business
• 29 Sep 14
